GlassScriptPhysician profile
Errol M Hook
NPI 1225017445
$7,755.13
in general payments reported to CMS, 2019-2025
36 companies · $1,840 in 2025
The $1,840 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,003 · 2022: $1,196 · 2023: $1,940 · 2024: $1,777 · 2025: $1,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,485 · Education: $71.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,484.97 |
| Education | $71.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,542.90 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $715.84 | 2021-2025 | Trelegy Ellipta, Nucala |
| Harmony Biosciences LLC | $658.78 | 2022-2025 | Wakix |
| Genzyme Corporation | $435.70 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $412.04 | 2021-2025 | Ofev, Jascayd, Stiolto Respimat |
| United Therapeutics Corporation | $370.12 | 2021-2024 | Tyvaso, Orenitram |
| Regeneron Healthcare Solutions, INC. | $346.45 | 2023-2025 | Dupixent |
| Genentech USA, INC. | $328.95 | 2021-2025 | Xolair |
| Insmed, INC. | $304.40 | 2021-2025 | Arikayce |
| Avadel Cns Pharmaceuticals, LLC | $295.77 | 2023-2025 | Lumryz |
| Actelion Pharmaceuticals US, INC. | $290.72 | 2022-2024 | Opsumit, Uptravi |
| La Jolla Pharmaceutical Company | $262.14 | 2021-2023 | Giapreza |
| Merck Sharp & Dohme LLC | $258.54 | 2021-2025 | Zerbaxa, Recarbrio, Winrevair |
| Mylan Specialty L.P. | $232.62 | 2021-2024 | Yupelri |
| Grifols USA, LLC | $202.65 | 2022-2025 | Prolastin-C Liquid |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $140.81 | 2021-2024 | |
| Amgen INC. | $112.59 | 2024-2025 | Tezspire |
| Abbvie INC. | $109.59 | 2021-2025 | |
| Philips North America LLC | $79.66 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.03 | 2023 | |
| Lilly USA, LLC | $63.66 | 2025 | Zepbound |
| Mallinckrodt Hospital Products INC. | $59.99 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.81 | 2021-2025 | Glassia |
| Gilead Sciences, INC. | $52.90 | 2021 | |
| Jazz Pharmaceuticals INC. | $48.66 | 2021-2025 | |
| Baxter Healthcare | $43.82 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Zoll Respicardia, INC. | $43.50 | 2022-2024 | Remede System |
| Alexion Pharmaceuticals, INC. | $41.77 | 2022 | |
| Arbor Pharmaceuticals, INC. | $36.25 | 2021 | |
| Verona Pharma, INC. | $29.65 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $19.75 | 2021 | |
| Inogen, INC. | $18.49 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Vapotherm INC | $16.96 | 2022 | |
| Advanced Respiratory, INC | $15.13 | 2021 | |
| Bioxcel Therapeutics, INC. | $14.88 | 2023 | Igalmi |
| Boston Scientific Corporation | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Errol Hook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.